Respected Madam/Sir, Please find attached Reappointment of Independent Director Suhas Thorat for the second term.

1st Oct 2026, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Dear Sir/Madam, Scrip Code: 539428 Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Management Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in compliance with the applicable provisions of the Companies Act, 2013, we hereby inform you that the members of the Company at the 18th Annual General Meeting of the Company held on Tuesday, 29th September, 2026 at 3.00 p.m. have approved the following: 1. Re-appointment of Mr. Suhas Vasantrao Thorat, (DIN: 09241231) as an Independent Director of the Company for a second term of 5 (five) consecutive years For, Tejnaksh Healthcare Limited Dr. Ashish V. Rawandale Managing Director DIN:- 02005733 Details of Directors seeking appointment / re-appointment at the 18th Annual General Meeting. (In pursuance of Regulations 26(4) and 36(3) of the Listing Regulations and Secretarial Standard-2 on General Meetings) Mr. Suhas Vasantrao Thorat (DIN: 09241231) Name of the Director Mr. SUHAS VASANTRAO THORAT Director Identification Number (DIN) 09241231 Designation Managing Director Date of Appointment 14/08/2021 Date of Birth 28/12/1966 Qualification Under graduate Expertise in specific functional areas He is having more than 15 years of experience as a manager and rich Knowledge of supervising and coordinating the administration. He is professional with good experience of Managerial Skills and handling team. He possesses a diverse knowledge and wide range of experience in the Managerial field. Relationship between Directors inter-se N.A Directorship held in other listed Companies NIL Membership/Chairmanships of committees of NIL other public companies (Includes only Audit Committee and Stakeholders Relationship Committee) Shareholding in the Company NIL